CRYSTAL ADAM (President, R&D) sold 25.5% of their position (38.46K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $961.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/17/2026ACC: 0001193125-26-159747
Officer· President, R&D
Since Feb 2026
-38.46K
Net shares
Net seller
$961.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
38.46K acquired · 76.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+38.46K
Price / share
$5.20
Trade value
$199.99K
% of position
34.1%
4/15/2026
112.62K→151.08K
Common Stock
Direct
Shares
−38.46K
Price / share
$25.00
Trade value
$961.50K
% of position
25.5%
4/15/2026
151.08K→112.62K
Total
Net shares
+0.00
Net value
-$761.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | M · Option Exercise | +38.46K | $5.20 | $199.99K | 34.1% | 112.62K | 151.08K |
| Common Stock Direct | 4/15/2026 | S · Sale | −38.46K | $25.00 | $961.50K | 25.5% | 151.08K | 112.62K |
| Total | +0.00 | -$761.51K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
38.46K shares
Shares
−38.46K
Strike price
5.2
Held after
395.04K
Exercisable
—
4/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock38.46K shares | 4/15/2026 | M · Option Exercise | −38.46K | 5.2 | — | 395.04K |